Nanoviricides (NNVC) Market Capitalization (2010 - 2026)

Nanoviricides has disclosed Market Capitalization across 17 years of filings, most recently posting $19.7 million for Q1 2026.

• In Q1 2026, Market Capitalization rose 5.0% year-over-year to $19.7 million; the TTM figure through Mar 2026 stood at $19.7 million (up 5.0% YoY), while the FY2025 annual figure was $23.2 million, up 2.84% from the prior year.
• Market Capitalization came in at $19.7 million for Q1 2026 at Nanoviricides, down from $24.4 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $25.1 million in Q3 2025 to a low of $12.0 million in Q4 2023.
• Average Market Capitalization over 5 years is $19.1 million, with a median of $20.1 million recorded in 2022.
• Year-over-year, Market Capitalization tumbled 69.9% in 2022 and soared 86.18% in 2024.
• Over 5 years, Market Capitalization stood at $12.9 million in 2022, then decreased by 6.97% to $12.0 million in 2023, then jumped by 86.18% to $22.4 million in 2024, then rose by 9.1% to $24.4 million in 2025, then declined by 19.09% to $19.7 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $19.7 million in Q1 2026, $24.4 million in Q4 2025, and $25.1 million in Q3 2025.